eumovate cream
glaxo smith kline (israel) ltd - clobetasone butyrate - cream - clobetasone butyrate 0.05 %w/w - clobetasone - clobetasone - eumovate cream is a moderately potent topical corticosteroid indicated for adults, elderly, children and infants for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses.these include the following:- atopic dermatitis- irritant or allergic contact dermatitis- seborrhoeic dermatitis- nappy rash- photodermatitis- otitis externa- prurigo nodularis- insect bite reactionseumovate may be used as maintenance therapy between courses of one of the more potent topical steroids.
betnovate cream
glaxo smith kline (israel) ltd - betamethasone as valerate - cream - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - betamethasone valerate is a potent topical corticosteroid indicated for adults, elderly and children over 1 year for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses.
betnovate ointment
glaxo smith kline (israel) ltd - betamethasone as valerate - ointment - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - betamethasone valerate is a potent topical corticosteroid indicated for adults, elderly and children over 1 year for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses.these include the following:atopic dermatitis (including infantile atopic dermatitis)nummular dermatitis (discoid eczema)prurigo nodularispsoriasis (excluding widespread plaque psoriasis)lichen simplex chronicus (neurodermatitis) and lichen planusseborrhoeic dermatitisirritant or allergic contact dermatitisdiscoid lupus erythematosusadjunct to systemic steroid therapy in generalised erythroderma
zeffix oral solution
glaxo smith kline (israel) ltd - lamivudine - solution (oral) - lamivudine 5 mg/ml - lamivudine - lamivudine - zeffix is indicated for the treatment of chronic hepatitis b associated with the evidence of hepatitis b viral (hbv) replication and active liver inflammation in adults and also in children and adolescents aged 2 to 17 years old.
priorix tetra
glaxo smith kline (israel) ltd - live attenuated measles virus; live attenuated mumps virus; live attenuated rubella virus; live attenuated varicella virus - powder and solvent for solution for injection - live attenuated measles virus 10^ 3.0 ccid50; live attenuated mumps virus 10^ 4.4 ccid50; live attenuated rubella virus 10^ 3.0 ccid50; live attenuated varicella virus 10^ 3.3 pfu - measles, combinations with mumps, rubella and varicella, live attenuated - measles, combinations with mumps, rubella and varicella, live attenuated - priorix-tetra is indicated for active immunisation against measles, mumps, rubella and varicella in children from the age of 12 months up and including 12 years of age.
infanrix ipv hib
glaxo smith kline (israel) ltd - diphtheria toxoid; fillamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin; pertussis toxoid (pt); tetanus toxoid - powder and suspension for suspension for injection - diphtheria toxoid nlt 60 iu/ml; inactivated polio virus (ipv) type 3 64 du / 1 ml; inactivated polio virus (ipv) type 2 16 du / 1 ml; inactivated polio virus (ipv) type 1 80 du / 1 ml; pertussis toxoid (pt) 50 mcg/ml; fillamentous haemagglutinin (fha) 50 mcg/ml; pertactin 16 mcg/ml; tetanus toxoid nlt 80 iu/ml; haemophilus influenzae type b polysaccharide 20 mcg/vial - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - active immunisation in infants from the age of 2 months to 5 years against diptheria, tetanus, pertussis, poliomyelitis and haemophilus influenza type b. booster dose for children who have previously been immunised with dtp, polio and hib antigens
imitrex injection
glaxo smith kline (israel) ltd - sumatriptan as succinate - solution for injection - sumatriptan as succinate 6 mg / 0.5 ml - sumatriptan - sumatriptan - subcutaneous injection is indicated for the acute relief of migraine attacks, with or without aura, and for the acute treatment of cluster headache.imitrex should only be used where there is a clear diagnosis of migraine or cluster headache.
imitrex tablets 100 mg
glaxo smith kline (israel) ltd - sumatriptan as succinate - film coated tablets - sumatriptan as succinate 100 mg - sumatriptan - sumatriptan - imitrex tablets are indicated for the acute relief of migraine attacks, with or without aura. imitrex should only be used where there is a clear diagnosis of migraine.
imitrex tablets 50 mg
glaxo smith kline (israel) ltd - sumatriptan as succinate - film coated tablets - sumatriptan as succinate 50 mg - sumatriptan - sumatriptan - imitrex tablets are indicated for the acute relief of migraine attacks, with or without aura. imitrex should only be used where there is a clear diagnosis of migraine.
imitrex nasal spray 20 mg
glaxo smith kline (israel) ltd - sumatriptan - solution - sumatriptan 20 mg / 0.1 ml - sumatriptan - sumatriptan - imitrex nasal spray is indicated for the acute treatment of migraine attacks with or without aura.